Search

Gerresheimer AG

Suletud

SektorTervishoid

28.98 3.87

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

28.72

Max

29.02

Põhinäitajad

By Trading Economics

Sissetulek

35M

18M

Müük

81M

601M

P/E

Sektori keskmine

40.059

37.461

Aktsiakasum

0.69

Dividenditootlus

0.15

Kasumimarginaal

2.934

Töötajad

13,535

EBITDA

35M

119M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+13.5% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.15%

2.33%

Turustatistika

By TradingEconomics

Turukapital

-772M

941M

Eelmine avamishind

25.11

Eelmine sulgemishind

28.98

Uudiste sentiment

By Acuity

50%

50%

147 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Gerresheimer AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. apr 2025, 10:15 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4. apr 2025, 09:39 UTC

Omandamised, ülevõtmised, äriostud

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

Gerresheimer AG Prognoos

Hinnasiht

By TipRanks

13.5% tõus

12 kuu keskmine prognoos

Keskmine 32.96 EUR  13.5%

Kõrge 46 EUR

Madal 23 EUR

Põhineb 10 Wall Streeti analüütiku instrumendi Gerresheimer AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

3

Osta

5

Hoia

2

Müü

Tehniline skoor

By Trading Central

60.1 / 60.95Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

147 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
help-icon Live chat